Avadel Pharmaceuticals Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.08%178.890.7%$1150.86m
LLYEli Lilly & Co. 1.17%374.681.1%$1117.28m
MRKMerck & Co., Inc. 0.22%110.040.7%$1021.82m
PFEPfizer Inc. -0.37%50.890.9%$965.33m
ABBVAbbVie, Inc. 1.24%163.641.9%$868.91m
BMYBristol-Myers Squibb Co. 0.27%81.101.1%$765.35m
AZNAstraZeneca Plc 0.19%68.471.0%$350.56m
HZNPHorizon Therapeutics Plc 3.94%104.855.4%$310.89m
IDXXIDEXX Laboratories, Inc. -0.88%435.303.9%$216.72m
CTLTCatalent, Inc. 0.13%52.301.9%$206.27m
GSKGSK Plc 0.89%35.340.3%$187.83m
NVSNovartis AG 0.15%89.950.2%$184.65m
ALNYAlnylam Pharmaceuticals, Inc. 6.43%234.408.0%$174.69m
NVONovo Nordisk A/S 0.62%126.910.1%$165.68m
SRPTSarepta Therapeutics, Inc. 2.66%126.2512.4%$128.59m

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on the approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded in 1990 and is headquartered in Dublin, Ireland.